| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |